Creo Medical Group Insider Buyers Pleased With UK£1.0m Return On Investment

Insiders who bought Creo Medical Group PLC (LON:CREO) stock lover the last 12 months are probably not as affected by last week’s 11% loss. After accounting for the recent loss, the UK£2.10m worth of shares they purchased is now worth UK£3.13m, suggesting a good return on their investment.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

See our latest analysis for Creo Medical Group

The Last 12 Months Of Insider Transactions At Creo Medical Group

Over the last year, we can see that the biggest insider purchase was by insider Luis Collantes for UK£888k worth of shares, at about UK£0.20 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of UK£0.30. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

Creo Medical Group insiders may have bought shares in the last year, but they didn't sell any. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Creo Medical Group Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. From our data, it seems that Creo Medical Group insiders own 4.6% of the company, worth about UK£4.7m. We do generally prefer see higher levels of insider ownership.

So What Does This Data Suggest About Creo Medical Group Insiders?

It doesn't really mean much that no insider has traded Creo Medical Group shares in the last quarter. However, our analysis of transactions over the last year is heartening. The transactions are fine but it'd be more encouraging if Creo Medical Group insiders bought more shares in the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To that end, you should learn about the 2 warning signs we've spotted with Creo Medical Group (including 1 which is concerning).

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.